AnticoagEvaluator
Detailed App Info:
Application Description
The American College of Cardiology’s AnticoagEvaluator is an easy and fast way to assess stroke and bleeding risk and the benefits and risks of antithrombotic therapy in patients with chronic atrial fibrillation.
Features:
• A combination risk calculator tool that uses CHADS2, CHA2DS2-VASc, and HAS-BLED
• Users can enter patient characteristics at the point of care and get individualized annual risk of ischemic stroke and thromboembolism with concurrent annual risk of major bleed
• Compare antithrombotic therapy options based on clinical trials (ACTIVE-A, RE-LY, ROCKET-AF, ARISTOTLE)
This app is adapted from a web tool created by Peter Loewen, B.Sc.(Pharm), ACPR, Pharm.D., FCSHP and can be viewed at http://www.sparctool.com/
Features:
• A combination risk calculator tool that uses CHADS2, CHA2DS2-VASc, and HAS-BLED
• Users can enter patient characteristics at the point of care and get individualized annual risk of ischemic stroke and thromboembolism with concurrent annual risk of major bleed
• Compare antithrombotic therapy options based on clinical trials (ACTIVE-A, RE-LY, ROCKET-AF, ARISTOTLE)
This app is adapted from a web tool created by Peter Loewen, B.Sc.(Pharm), ACPR, Pharm.D., FCSHP and can be viewed at http://www.sparctool.com/
Requirements
Your mobile device must have at least 13.33 MB of space to download and install AnticoagEvaluator app. AnticoagEvaluator was updated to a new version. Purchase this version for $0.00
If you have any problems with installation or in-app purchase, found bugs, questions, comments about this application, you can visit the official website of American College of Cardiology at http://www.cardiosource.org/science-and-quality/clinical-tools/mobile-resources.aspx.
Copyright © 2013 American College of Cardiology, Interact Multimedia Corporation, Dr. Peter Loewen
